Perinatal Depression

Obstetrics and Gynecology Clinics of North America

Volumn 35, Issue 3, 2008, Pages 419-434

  Dossett, Emily C ^a  

^a LAC USC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; AMFEBUTAMONE; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CITALOPRAM; CLONIDINE; CORTICOSTEROID; DIURETIC AGENT; DULOXETINE; FLUOXETINE; OPIATE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; VENLAFAXINE;

ANXIETY DISORDER; BREAST FEEDING; CLINICAL ASSESSMENT; CLINICAL FEATURE; COGNITIVE THERAPY; CONGENITAL MALFORMATION; DEVELOPMENTAL DISORDER; DISEASE COURSE; DRUG EFFICACY; EDINBURGH POSTNATAL DEPRESSION SCALE; GROUP THERAPY; HEART DISEASE; HUMAN; HYPERTENSION; LOW DRUG DOSE; NEWBORN DISEASE; OBSESSIVE COMPULSIVE DISORDER; PANIC; PERINATAL CARE; POSTTRAUMATIC STRESS DISORDER; PREMATURE LABOR; PRENATAL CARE; PREVALENCE; PRIORITY JOURNAL; PUERPERAL DEPRESSION; PULMONARY HYPERTENSION; REVIEW; RISK FACTOR; WITHDRAWAL SYNDROME;

DEPRESSIVE DISORDER; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL CARE; PSYCHOTHERAPY; PSYCHOTROPIC DRUGS;

EID: 49949095389     PISSN: 08898545     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ogc.2008.04.004     Document Type: Review

References (68)

1. Dayan J., Creveuil C., Marks M.N., et al. Prenatal depression, prenatal anxiety, and spontaneous preterm birth: a prospective cohort among women with early and regular antenatal care. Psychosom Med 68 (2006) 938-946
2. Evans J., Heron J., Patel R.R., et al. Depressive symptoms in pregnancy and low birth weight at term: longitudinal study. Br J Psychiatry 191 (2007) 84-85
3. Ciccheti D. Maternal depressive disorder and contextual risk: contributions to the development of attachment insecurity and behavior problems in toddlerhood. Dev Psychopathol 10 (1998) 283-300
4. Kim H.G., Mandell M., Crandall C., et al. Antenatal psychiatric illness and adequacy of prenatal care in an ethnically diverse inner-city obstetric population. Arch Womens Ment Health 9 (2006) 103-107
5. Flynn H.A., Walton M.A., Chermack S.T., et al. Brief detection and co-occurrence of violence, depression, and alcohol risk in prenatal care settings. Arch Womens Ment Health 10 (2007) 155-161
6. Murray C.A., and Lopez A.D. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 349 (1997) 1436-1442
7. Weissman M.M., Bland R.C., Canino G.J., et al. Cross-national epidemiology of major depression and bipolar disorder. JAMA 276 (1996) 293-299
8. Dietz P.M., Williams S.B., Callaghan W.M., et al. Clinically identified maternal depression before, during, and after pregnancies ending in live births. Am J Psychiatry 164 (2007) 1515-1520
9. Gaynes B.N., Gavin N., Meltzer-Brody S., et al. Perinatal depression: prevalence, screening accuracy, and screening outcomes. Summary, evidence report/technology assessment: number 119. AHRQ Publication Number 05-E006-1 (February 2005), Agency for Healthcare Research and Quality, Rockville (MD). http://www.ahrq.gov/clinic/epcsums/peridepsum.ht Accessed June 9, 2008
10. Rich-Edwards J.W., Kleinman K., Abrams A., et al. Sociodemographic predictors of antenatal and postpartum depressive symptoms among women in a medical group practice. J Epidemiol Community Health 60 (2006) 221-227
11. Howell E.A., Mora P., and Leventhal H. Correlates of early postpartum depressive symptoms. Matern Child Health J 10 (2006) 149-157
12. Orr S.T., Blazer D.G., James S.A., et al. Depressive symptoms and indicators of maternal health status during pregnancy. Arch Womens Ment Health 16 4 (2007) 535-542
13. Nicholson W.K., Setse R., Hill-Briggs F., et al. Depressive symptoms and health related quality of life in early pregnancy. Obstet Gynecol 107 4 (2006) 798-806
14. Glynn L.M., Schetter C.D., Hobel C.J., et al. Pattern of perceived stress and anxiety in pregnancy predicts preterm birth. Health Psychol 27 (2008) 43-51
15. Halbreich U. The association between pregnancy processes, preterm delivery, low birth weight, and postpartum depressions: the need for interdisciplinary integration. Am J Obstet Gynecol 193 (2005) 1312-1322
16. Henderson J.J., Evans S.F., Straton J.A., et al. Impact of postnatal depression on breastfeeding duration. Birth 30 (2003) 175-180
17. Buist A. Childhood abuse, postpartum depression, and parenting difficulties: a literature review of associations. Aust N Z J Psychiatry 32 (1998) 37-38
18. The World Health Organization. The importance of caregiver-child interactions for the survival and healthy development of young children: a review. 2004. Available at: (2004). http://www.cho.int/child-adolescent- Accessed June 9, 2008
19. Feldman R., Weller A., Leckman J.F., et al. The nature of the mother's tie to her infant: maternal bonding under conditions of proximity, separation, and potential loss. J Child Psychol Psychiatry 40 (1999) 929-939
20. Ross L.E., and McLean L.M. Anxiety disorders during pregnancy and the postpartum period: a systematic review. J Clin Psychiatry 67 (2006) 1285-1298
21. Talge N.M., Neal C., and Glover V. Antenatal maternal stress and long term effects on child neurodevelopment: how and why?. J Child Psychol Psychiatry 48 (2007) 245-261
22. Van der Wal M.F., van Eijsden M., and Bonsel G. Stress and emotional problems during pregnancy and excessive infant crying. J Dev Behav Pediatr 28 (2007) 421-427
23. Hofberg K., and Ward M.R. Fear of childbirth, tocophobia, and mental health in mothers: the obstetric-psychiatric interface. Clin Obstet Gynecol 47 (2004) 527-534
24. Gamble J.A., and Creedy D.K. Women's preference for a caesarean section: incidence and associated factors. Birth 28 (2001) 101-111
25. Heron J., O'Connor T.G., Evans J., et al. The course of anxiety and depression through pregnancy and the postpartum in a community sample. J Affect Disord 80 (2004) 65-73
26. Lee A.M., Lam S.K., Sze Mun Lau S.M., et al. Prevalence, course, and risk factors for antenatal anxiety and depression. Obstet Gynecol 110 (2007) 1102-1112
27. Neilsen Forman D., Videbech P., Hedegaard M., et al. Postpartum depression: identification of women at risk. BJOG 107 (2000) 1210-1217
28. Johnstone S.J., Boyce P.M., Hickey A.R., et al. Obstetric risk factors for postnatal depression in urban and rural community samples. Aust N Z J Psychiatry 35 (2001) 69-74
29. Tammentie T., Paavilainen E., Astedt-Kurki P., et al. Family dynamics of postnatally depressed mothers: discrepancy between expectations and reality. J Clin Nurs 13 (2004) 65-74
30. Spitzer R., Kroenke K., and Williams J.B. Validity and utility of a self-report version of PRIME-MD: the PHQ primary care study. JAMA 282 (1999) 1737-1744
31. Kroenke K., Spitzer R., and Williams J.B. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16 (2001) 606-613
32. Spitzer R.L., Williams J.B., Kroenke K., et al. Validity and utility of the PRIME-MD patient health questionnaire in assessment of 3000 obstetric-gynecologic patients: the PRIME-MED patient health questionnaire obstetrics-gynecology study. Am J Obstet Gynecol 183 (2000) 759-769
33. The Macarthur initiative on depression and primary care at Dartmouth and Duke. Depression management tool kit, 2004 June. Available at:. http://www.depression-primarycare.org Accessed June 9, 2008
34. Murray L., and Carothers A.D. The validation of the Edinburgh Post-Natal Depression Scale on a community sample. Br J Psychiatry 157 (1990) 288-290
35. Whooley M.A., Avins A.L., Miranda J., et al. Case-finding instruments for depression: two questions are as good as many. J Gen Intern Med 12 (1997) 439-445
36. Kroenke K., Spitzer R., and Williams J.B. The patient health questionnaire-2: validity of a two-item depression screener. Med Care 41 (2003) 1284-1292
37. American College of Obstetricians and Gynecologists. ACOG Committee Opinion No.343. Obstet Gynecol 108 (2006) 469-477
38. Munk-Olsen T., Laursen T.M., Pedersen C.B., et al. New parents and mental disorders: a population-based register study. JAMA 296 (2006) 2582-2589
39. Wells K.B. The design of partners in care: evaluating the cost-effectiveness of improving care for depression in primary care. Soc Psychiatry Psychiatr Epidemiol 34 (1999) 20-29
40. American Psychiatric Association. Diagnostic and statistical manual of mental disorders: DSM-IV-TR 4th ed. text version. edition 4 (1994) Washington, DC: APA, 2000
41. National Mental Health Association. America's mental health survey, May 2000. Conducted by Roper Starch Worldwide, Inc. Available at:. www.roper.com/Newsroom/content/news189.htm Accessed June 9, 2008
42. Cohen L.S., Altshuler L.L., and Harlow B.L. Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA 295 (2006) 499-507
43. Zlotnick C., Johnson S.L., Miller I.W., et al. Postpartum depression in women receiving public assistance: a pilot study of an interpersonal-therapy-oriented group intervention. Am J Psychiatry 158 (2001) 638-640
44. Zlotnick C., Miller I.W., and Pearlstein T. A preventive intervention for pregnant women on public assistance at risk for postpartum depression. Am J Psychiatry 163 (2006) 1443-1445
45. Milgrom J., Negri L.M., and Gemmill A.W. A randomized controlled trial of psychological interventions for postnatal depression. Br J Clin Psychol 44 Pt 4 (2005) 529-542
46. Austin M.P., Frilingos M., Lumley J., et al. Brief antenatal cognitive behavior group intervention for the prevention of postnatal depression and anxiety: a randomized controlled trial. J Affect Disord 105 (2008) 35-44
47. Misri S., Reebye P., Corral M., et al. The use of paroxetine and cognitive-behavioral therapy in postpartum depression and anxiety: a randomized controlled trial. J Clin Psychiatry 65 (2004) 1236-1241
48. Misri S., Kostaras X., Fox D., et al. The impact of partner support in the treatment of postpartum depression. Can J Psychiatry 45 (2000) 55408
49. Reid M., Glazener C., Reid M., et al. A two-centred pragmatic randomized controlled trial of two interventions of postnatal support. BJOG 109 (2002) 1164-1170
50. Vaswani M., Linda F.K., and Ramesh S. Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review. Prog Neuropsychopharmacol Biol Psychiatry 27 (2003) 85-102
51. Trevida M.H., Rush A.J., Wisniewski S.R., et al. Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 16 (2006) 28-45
52. Einarson T.R., and Einarson A. Newer antidepressants in pregnancy and rates of major malformations: a meta-analysis of prospective comparison studies. Pharmacoepidemiol Drug Saf 14 (2005) 823-827
53. Wogelius P., Norgaard M., Gislum M., et al. Maternal use of selective serotonin reuptake inhibitors and risk of congenital malformations. Epidemiology 17 (2006) 701-704
54. Louik C., Lin A.E., Werler M.M., et al. First-trimester use of selective serotonin-reuptake inhibitors and the risk of birth defects. N Engl J Med 356 (2007) 2675-2683
55. Alwin S., Reefhuis J., and Rasmussen S.A. Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med 356 (2007) 2684-2692
56. Thormahlen G.M. Paroxetine use during pregnancy: is it safe?. Ann Pharmacother 40 (2006) 2281-2282
57. Suri R., Altshuler L., Hellemann G., et al. Effects of antenatal depression and antidepressant treatment on gestational age at birth and risk of preterm birth. Am J Psychiatry 16 (2007) 1206-1213
58. Koren G., Matsui D., Einarson A., et al. Is maternal use of selective serotonin reuptake inhibitors in the third trimester of pregnancy harmful to neonates?. CMAJ 172 (2005) 1457-1459
59. Sanz E.J., De-las-Cuevas C., Kiuru A., et al. Selective serotonin reuptake inhibitors in pregnant women and neonatal withdrawal syndrome: a database analysis. Lancet 365 (2005) 482-487
60. Clinical Management Guidelines for Obstetrician-Gynecologist. Use of psychiatric medications during pregnancy and lactation. ACOG Practice Bulletin #92 (2008), Elsevier, St. Louis, MO
61. Moses-Kolko E.L., Bogen D., and Perel J. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA 293 (2005) 2372-2383
62. Chambers C.D., Hernandez-Diaz S., Van Marter L.J., et al. Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn. N Engl J Med 354 (2006) 579-587
63. Nulman I., Rovet J., Stewart D.E., et al. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 336 (1997) 258-262
64. Nulman I., Rovet J., Stewart D.E., et al. Child development following exposure to tricyclic antidepressants or fluoxetine throughout fetal life: a prospective controlled study. Am J Psychiatry 59 (2002) 1889-1895
65. Casper R.C., Fleisher B.E., Lee-Ancajas J.C., et al. Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr 42 (2003) 402-408
66. Einarson A., Fatoye B., Sarkar M., et al. Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study. Am J Psychiatry 158 (2001) 1728-1730
67. Chun-Fai-Chan B., Koren G., Fayez I., et al. Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study. Am J Obstet Gynecol 192 (2005) 932-936
68. Weissman A.M., Levy B.T., and Hartz A.J. Pooled analysis of antidepressant levels in lactating mothers, breast milk, and nursing infants. Am J Psychiatry 161 (2004) 1066-1078